| Trial ID: | L1341 |
| Source ID: | NCT00502268
|
| Associated Drug: |
Doxercalciferol Administration
|
| Title: |
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Coronary Calcification|Endstage Renal Disease|Parathyroid Hormone
|
| Interventions: |
DRUG: Doxercalciferol administration|DRUG: Doxercalciferol administered by 1-84-7-84
|
| Outcome Measures: |
Primary: Percent Change in Hounsfield units of coronary calcification between baseline and after one year of therapy, 12 months | Secondary: Mean dose of Vitamin D2 administered over 12 months, 12 months
|
| Sponsor/Collaborators: |
Sponsor: Southeast Renal Research Institute
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
|
| Start Date: |
2008-02
|
| Completion Date: |
2009-07
|
| Results First Posted: |
|
| Last Update Posted: |
2020-12-23
|
| Locations: |
Davita East Charlotte Dialysis Unit, Charlotte, North Carolina, 28208, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00502268
|
